Researchers have developed a method for producing blood stem cells anywhere in the body, potentially eliminating the need for bone marrow donors. This could revolutionize the treatment of blood disorders such as myelofibrosis.

How blood stem cells are produced

Endothelial cells in the bone marrow help generate different types of blood cells. These cells create a nurturing home, known as a niche, in which stem cells can divide and produce new ones. However, genetic mutations in bone marrow cells can cause blood disorders, necessitating bone marrow transplantation.

Creating a blood stem cell niche

Researchers used a zebrafish model to study how a stem cell niche is formed. They isolated endothelial cells and found that a combination of three transcription factor families – Ets, SoxF, and Nuclear Hormone Receptor (NHR) – was necessary to form a stem cell niche. By injecting these factors into zebrafish embryos, they successfully created a new niche.

Promising results

The researchers were surprised to find that the newly created endothelial cells attracted a large number of blood stem cells, confirming their functionality as a stem cell niche. These stem cells remained in the new niche for several hours and underwent multiple divisions.

Implications and challenges ahead

This discovery could potentially change the treatment of blood disorders by providing alternative sites for stem cell production. The liver and spleen, which can develop cells involved in the immune system, are potential locations for establishing new niches.

However, translating these findings to humans poses a challenge. Researchers need to determine if the identified transcription factors can induce niche formation in humans. If successful, this study could pave the way for human trials and revolutionize blood disorder treatment.